Cooperative cell transformation by Myc/Mil(Raf) involves induction of AP-1 and activation of genes implicated in cell motility and metastasis

Oncogene

Volumn 25, Issue 29, 2006, Pages 4043-4055

  Hartl, M ^a   Karagiannidis, A I ^a   Bister, K ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Activator protein 1; Cell transformation; Gene regulation; Osteopontin; Target gene; Transcriptional control

Indexed keywords

ACTIN; CYTOKINE; GUANOSINE TRIPHOSPHATASE; MYC PROTEIN; OSTEOPONTIN; PROTEIN; PROTEIN C JUN; PROTEIN S 100; RAC2 PROTEIN; RAF PROTEIN; RETROVIRUS VECTOR; RHO FACTOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CALCIUM BINDING; CARCINOGENICITY; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; CELL TRANSFORMATION; CHROMATIN; CONSENSUS; CONTROLLED STUDY; CYTOKINE RELEASE; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENETIC ANALYSIS; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C FOS; PRECIPITATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; REPORTER GENE; TRANSCRIPTION INITIATION SITE; TUMOR GROWTH;

ALPHARETROVIRUS; ANIMALS; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; CHICK EMBRYO; CHICKENS; COTURNIX; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, JUN; GENES, MYC; HUMANS; NEOPLASM METASTASIS; ONCOGENE PROTEINS V-RAF; OSTEOPONTIN; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-FOS; RAC GTP-BINDING PROTEINS; SIALOGLYCOPROTEINS; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

AVES;

EID: 33745767294     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209441     Document Type: Article

References (62)

1. Bader AG, Schneider ML, Bister K, Hartl M. (2001). Oncogene 20: 7524-7535.
2. Bidder M, Shao JS, Charlton-Kachigian N, Loewy AP, Semenkovich CF, Towler DA. (2002). J Biol Chem 277: 44485-44496.
3. Bister K, Hayman MJ, Vogt PK. (1977). Virology 82: 431-448.
4. Bister K, Jansen HW. (1986). Adv Cancer Res 47: 99-188.
5. Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN, Weintraub H. (1990). Science 250: 1149-1151.
6. Blackwood EM, Eisenman RN. (1991). Science 251: 1211-1217.
7. Castagnola P, Bet P, Quarto R, Gennari M, Cancedda R. (1991). J Biol Chem 266: 9944-9949.
8. Chamboredon S, Briggs J, Vial E, Hurault J, Galvagni F, Oliviero S et al. (2003). Oncogene 22: 4047-4061.
9. Curran T, Franza BR. (1988). Cell 55: 395-397.
10. Dang CV. (1999). Mol Cell Biol 19: 1-11.
11. Denhardt DT, Giachelli CM, Rittling SR. (2001). Annu Rev Pharmacol Toxicol 41: 723-749.
12. Didsbury J, Weber RF, Bokoch GM, Evans T, Snyderman R. (1989). J Biol Chem 264: 16378-16382.
13. Donato R. (1999). Biochim Biophys Acta 1450: 191-231.
14. Duesberg PH, Bister K, Vogt PK. (1977). Proc Natl Acad Sci USA 74: 4320-4324.
15. Eferl R, Wagner EF. (2003). Nat Rev Cancer 3: 859-868.
16. Eisenman RN. (2001). Genes Dev 15: 2023-2030.
17. El-Tanani M, Platt-Higgins A, Rudland PS, Campbell FC. (2004). J Biol Chem 279: 20794-20806.
18. Graf T, von Weizsäcker F, Grieser S, Coll J, Stehelin D, Patschinsky T et al. (1986). Cell 45: 357-364.
19. Grandori C, Cowley SM, James LP, Eisenman R. (2000). Annu Rev Cell Dev Biol 16: 653-699.
20. Hartl M, Bister K. (1998). Oncogene 17: 2901-2913.
21. Hartl M, Matt T, Schüler W, Siemeister G, Kontaxis G, Kloiber K et al. (2003). J Mol Biol 333: 33-46.
22. Hartl M, Reiter F, Bader AG, Castellazzi M, Bister K. (2001). Proc Natl Acad Sci USA 98: 13601-13606.
23. Hughes SH, Greenhouse JJ, Petropoulos CJ, Sutrave P. (1987). J Virol 61: 3004-3012.
24. Jackson RJ, Howell MT, Kaminski A. (1990). Trends Biochem Sci 15: 477-483.
25. Jaffe AB, Hall A. (2005). Annu Rev Cell Dev Biol 21: 247-269.
26. Jansen HW, Lurz R, Bister K, Bonner TI, Mark GE, Rapp UR. (1984). Nature 307: 281-284.
27. Jansen HW, Patschinsky T, Bister K. (1983a). J Virol 48: 61-73.
28. Jansen HW, Rückert B, Lurz R, Bister K. (1983b). EMBO J 2: 1969-1975.
29. Kerkhoff E, Bister K, Klempnauer K-H. (1991). Proc Natl Acad Sci USA 88: 4323-4327.
30. Kerkhoff E, Rapp UR. (1998). Oncogene 17: 1457-1462.
31. Kurisu S, Suetsugu S, Yamazaki D, Yamaguchi H, Takenawa T. (2005). Oncogene 24: 1309-1319.
32. Kuykindoll RJ, Nishimura H, Thomason DB, Nishimoto SK. (2000). J Exp Biol 203: 273-282.
33. Lefevre G, Calipel A, Mouriaux F, Hecquet C, Malecaze F, Mascarelli F. (2003). Oncogene 22: 8813-8822.
34. Marenholz I, Heizmann CW, Fritz G. (2004). Biochem Biophys Res Commun 322: 1111-1122.
35. Merezak C, Pierreux C, Adam E, Lemaigre F, Rousseau GC, Calomme C et al. (2001). J Virol 75: 6977-6988.
36. Mi Z, Guo H, Wai PY, Gao C, Wei J, Kuo PC. (2004). J Biol Chem 279: 46659-46667.
37. Moye VE, Barraclough R, West C, Rudland PS. (2004). Br J Cancer 90: 1796-1802.
38. Nakano T, Graf T. (1992). Oncogene 7: 527-534.
39. Patschinsky T, Bister K. (1988). Oncogene 3: 357-364.
40. Polsky D, Cordon-Cardo C. (2003). Oncogene 22: 3087-3091.
41. Rafidi K, Simkina I, Johnson E, Moore MA, Gerstenfeld LC. (1994). Gene 140: 163-169.
42. Ransone LJ, Verma IM. (1990). Annu Rev Cell Biol 6: 539-557.
43. Rapp UR, Cleveland JL, Fredrickson TN, Holmes KL, Morse III HC, Jansen HW et al. (1985). J Virol 55: 23-33.
44. Rapp UR, Goldsborough MD, Mark GE, Bonner TI, Groffen J, Reynolds Jr FH et al. (1983). Proc Natl Acad Sci USA 80: 4218-4222.
45. Rapp UR, Troppmair J, Beck T, Birrer MJ. (1994). Oncogene 9: 3493-3498.
46. Rittling SR, Chambers AF. (2004). Br J Cancer 90: 1877-1881.
47. Saez E, Rutberg SE, Mueller E, Oppenheim H, Smoluk J, Yuspa SH et al. (1995). Cell 82: 721-732.
48. Sakata R, Minami S, Sowa Y, Yoshida M, Tamaki T. (2004). Biochem Biophys Res Commun 315: 959-963.
49. Senger DR, Wirth DF, Hynes RO. (1979). Cell 16: 885-893.
50. Shaulian E, Karin M. (2002). Nat Cell Biol 4: E131-E136.
51. Sherwood DR, Butler JA, Kramer JM, Sternberg PW. (2005). Cell 121: 951-962.
52. Shyy JY, Lin MC, Han J, Lu Y, Petrime M, Chien S. (1995). Proc Natl Acad Sci USA 92: 8069-8073.
53. Simpson PT, Shoker BS, Barraclough R, Halliwell N, Rudland PS, Sibson DR et al. (2003). Int J Exp Pathol 84: 173-184.
54. Sørensen ES, Højrup P, Petersen TE. (1995). Protein Sci 4: 2040-2049.
55. Sutrave P, Bonner TI, Rapp UR, Jansen HW, Patschinsky T, Bister K. (1984). Nature 309: 85-88.
56. Suzuki T, Murakami M, Onai N, Fukuda E, Hashimoto Y, Sonobe MH et al. (1994). J Virol 68: 3527-3535.
57. Teramoto H, Castellone MD, Malek RL, Letwin N, Frank B, Gutkind JS et al. (2005). Oncogene 24: 489-501.
58. Tikhonenko AT, Linial ML. (1992). J Virol 66: 946-955.
59. Vogt PK. (2002). Nat Rev Cancer 2: 465-469.
60. Vogt PK, Bos TJ. (1990). Adv Cancer Res 55: 1-35.
61. Weber GF. (2001). Biochim Biophys Acta 1552: 61-85.
62. Wellbrock C, Karasarides M, Marais R. (2004). Nat Rev Mol Cell Biol 5: 875-885.